Technology
Health
Biotechnology

Galectin Therapeutics

$3.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.51%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell GALT and other stocks, options, ETFs, and crypto commission-free!

About GALT

Galectin Therapeutics Inc. Common Stock, also called Galectin Therapeutics, is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Read More Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Employees
6
Headquarters
Norcross, Georgia
Founded
2000
Market Cap
181.01M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
426.99K
High Today
$4.04
Low Today
$3.87
Open Price
$3.95
Volume
218.23K
52 Week High
$6.98
52 Week Low
$3.17

Collections

Technology
Health
Biotechnology
Therapy
Research And Development
Cancer Prevention
US
North America

GALT Earnings

-$0.20
-$0.16
-$0.11
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 14, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.